Hepatitis C NS5B Drug Resistance HEPCNS5B

Synonyms

Allscripts (AEHR) Order Name

Hepatitis C Virus (HCV) NS5B Drug Resistance Assay

Sunrise Clinical Manager (SCM) Order Name

Hepatitis C NS5B Drug Resistance

Clinical Info

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5B inhibitors. Assay should be used for patients with documented HCV genotype 1.

Specimen Type

Container

Lavender Top Tube

Collection Instructions

Container/Tube:   Two Lavender-top (EDTA) tubes or two PPT™ tubes
Specimen: 2 mL EDTA plasma (1 mL min)
Transport Temperature: Frozen EDTA plasma (PPT™ tubes can be spun and frozen)
Collection : Centrifuge specimen within six hours of collection, remove serum/plasma, and transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen.
 
 
Special Instructions Please indicate the patient's HCV genotype (1a or 1b) on the test request form
 
 

Transport Instructions

Frozen EDTA plasma (PPT™ tubes can be spun and frozen)

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Days Performed

Performing Laboratory

LabCorp-Monogram Bioscience

CPT

87900
87902
 
TAT: 11- 15 Days

PDM

5908815

Result Interpretation

See Report
 
This procedure may not be successful when the HCV viral load is <1000 IU/mL. This assay requires an HCV genotype of either 1a or 1b.

Forms